Sign In
Get Clay Free →

Suggestions

    Chris Gibson

    Co-Founder/CEO Recursion: a biotech scaling more like a tech company - Nasdaq:RXRX | Reimagining the Future of Biotech

    Chris Gibson is a highly accomplished individual with a strong background in bioengineering, entrepreneurial studies, and medicine.

    He is the founder and CEO of Recursion, a pioneering digital biology company focused on revolutionizing drug discovery through the fusion of automation, artificial intelligence, and biological data.

    Under his leadership, Recursion has advanced numerous clinical-stage and pre-clinical programs across various therapeutic areas, aiming to accelerate the development of life-changing medicines.

    With a Ph.D. in Bioengineering from the University of Utah and a Doctor of Medicine degree, Chris brings a unique blend of scientific expertise and business acumen to his endeavors.

    He is dedicated to leveraging technology and innovation to drive advancements in medicine, aiming to improve patient outcomes and reduce healthcare costs.

    In addition to his work at Recursion, Chris is actively involved in mentoring and supporting emerging biotech entrepreneurs, demonstrating his commitment to nurturing the next generation of scientific innovators.

    Highlights

    Feb 19 · TechCrunch
    NIH funding uncertainty spurs new biotech venture fund
    NIH funding uncertainty spurs new biotech venture fund
    Jun 25 · Benzinga
    Recursion Pharmaceuticals Stock Is Moving Tuesday: What's Happening? - Recursion Pharmaceuticals (NASDAQ ... - Benzinga
    Recursion Pharmaceuticals Stock Is Moving Tuesday: What's Happening? - Recursion Pharmaceuticals (NA
    Chris Gibson
    Add to my network

    Location

    Salt Lake City, Utah, United States